Chemoinformaics analysis of 10-Deacetylcephalomannine
| Molecular Weight | 789.875 | nRot | 9 |
| Heavy Atom Molecular Weight | 738.467 | nRig | 39 |
| Exact Molecular Weight | 789.336 | nRing | 6 |
| Solubility: LogS | -4.38 | nHRing | 1 |
| Solubility: LogP | 3.369 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 108 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 57 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 51 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 43 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 12 |
| nHA | 13 | APOL | 117.342 |
| nHD | 5 | BPOL | 63.0176 |
| QED | 0.18 |
| Synth | 6.15 |
| Natural Product Likeliness | 1.674 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.24 |
| HIA | 0.38 |
| CACO-2 | -5.285 |
| MDCK | 0.0000319 |
| BBB | 0.026 |
| PPB | 0.940243 |
| VDSS | 0.809 |
| FU | 0.0303536 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.086 |
| CYP2c19-inh | 0.15 |
| CYP2c19-sub | 0.241 |
| CYP2c9-inh | 0.352 |
| CYP2c9-sub | 0.08 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.098 |
| CYP3a4-inh | 0.873 |
| CYP3a4-sub | 0.789 |
| CL | 6.449 |
| T12 | 0.024 |
| hERG | 0.057 |
| Ames | 0.016 |
| ROA | 0.972 |
| SkinSen | 0.019 |
| Carcinogencity | 0.02 |
| EI | 0.004 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.826 |
| Antiviral | Yes |
| Prediction | 0.941014 |